KR20150076999A - Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity - Google Patents
Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity Download PDFInfo
- Publication number
- KR20150076999A KR20150076999A KR1020130165789A KR20130165789A KR20150076999A KR 20150076999 A KR20150076999 A KR 20150076999A KR 1020130165789 A KR1020130165789 A KR 1020130165789A KR 20130165789 A KR20130165789 A KR 20130165789A KR 20150076999 A KR20150076999 A KR 20150076999A
- Authority
- KR
- South Korea
- Prior art keywords
- oyster
- extract
- freeze
- methanol
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 109
- 230000002087 whitening effect Effects 0.000 title claims abstract description 26
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 20
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title description 12
- 241000548230 Crassostrea angulata Species 0.000 title description 2
- 241000237502 Ostreidae Species 0.000 claims abstract description 143
- 235000020636 oyster Nutrition 0.000 claims abstract description 141
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000002537 cosmetic Substances 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000004108 freeze drying Methods 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 238000010298 pulverizing process Methods 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims description 28
- 239000006071 cream Substances 0.000 description 55
- 238000003860 storage Methods 0.000 description 22
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 20
- 239000000401 methanolic extract Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 230000002401 inhibitory effect Effects 0.000 description 16
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 15
- 102000003425 Tyrosinase Human genes 0.000 description 15
- 108060008724 Tyrosinase Proteins 0.000 description 15
- 230000002292 Radical scavenging effect Effects 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 239000000469 ethanolic extract Substances 0.000 description 8
- 235000019624 protein content Nutrition 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000007602 hot air drying Methods 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108091023288 HOTAIR Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102400000686 Endothelin-1 Human genes 0.000 description 2
- 101800004490 Endothelin-1 Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- -1 body cleanser Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 1
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 241000519889 Crassostrea nippona Species 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241001262162 Ostrea denselamellosa Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- OHDRQQURAXLVGJ-AXMZSLBLSA-N azane;(2z)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-AXMZSLBLSA-N 0.000 description 1
- 239000012754 barrier agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940041967 corticotropin-releasing hormone Drugs 0.000 description 1
- KLVRDXBAMSPYKH-RKYZNNDCSA-N corticotropin-releasing hormone (human) Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(C)C)C1=CNC=N1 KLVRDXBAMSPYKH-RKYZNNDCSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 동결건조한 후 분쇄한 굴 분말을 메탄올로 추출하여 제조하는 것을 특징으로 하는 항산화 및 미백 활성이 증진된 굴 추출물의 제조방법, 상기 방법으로 제조된 항산화 및 미백 활성이 증진된 굴 추출물 및 상기 굴 추출물을 유효성분으로 함유하는 미백용 화장료 조성물에 관한 것이다.The present invention relates to a method for preparing oyster extract having enhanced antioxidant and whitening activity, which comprises preparing oyster powder after freeze-drying and pulverization by extracting with methanol, oyster extract having enhanced antioxidative and whitening activity, The present invention relates to a cosmetic composition for whitening comprising oyster extract as an active ingredient.
Description
본 발명은 동결건조한 후 분쇄한 굴 분말을 메탄올로 추출하여 제조하는 것을 특징으로 하는 항산화 및 미백 활성이 증진된 굴 추출물의 제조방법, 상기 방법으로 제조된 항산화 및 미백 활성이 증진된 굴 추출물 및 상기 굴 추출물을 유효성분으로 함유하는 미백용 화장료 조성물에 관한 것이다.The present invention relates to a method for preparing oyster extract having enhanced antioxidant and whitening activity, which comprises preparing oyster powder after freeze-drying and pulverization by extracting with methanol, oyster extract having enhanced antioxidative and whitening activity, The present invention relates to a cosmetic composition for whitening comprising oyster extract as an active ingredient.
경제성장과 식생활의 서구화로 비만, 당뇨, 고혈압, 고콜레스테롤증, 암 등 다양한 생활 습관병이 크게 증가하고 있으며 이들 질환은 자유 라디칼과의 관련성이 대두되고 있다. 자유 라디칼은 생체막에 존재하는 불포화 지방산을 산화시켜 세포의 불활성화를 일으키는 작용을 통하여 노화 및 각종 질병 발생에 기여하는 것으로 알려져 있다. 따라서 이들에 의한 산화작용으로부터 생체를 보호하고 노화를 예방하기 위하여 항산화 방어계를 강화시키는 생리활성물질의 개발이 요구되고 있다.The westernization of economic growth and eating habits greatly increases the diverse lifestyle diseases such as obesity, diabetes, hypertension, hypercholesterolemia, and cancer, and these diseases are linked to free radicals. Free radicals are known to oxidize unsaturated fatty acids present in the biomembrane and cause cell deactivation, thereby contributing to aging and the development of various diseases. Therefore, it is required to develop a physiologically active substance which strengthens the antioxidant defense system in order to protect the living body from oxidative action by them and prevent aging.
피부가 자외선 자극을 받으면 각질형성세포(keratinocyte)에서 ET-1(endothelin-1), 부실피질 자극 호르몬, 일산화 질소(NO) 등이 분비되어 피부색소가 증가하게 된다. 피부 색소는 기저층에 존재하는 멜라닌 세포가 만들어내는 멜라닌의 함량에 의해 결정되며, 이러한 멜라닌은 자연계에 널리 존재하는 생체 고분자 물질로 자외선이나 자유 라디칼로부터 피부가 손상되는 것을 방지하는 역할을 담당하고 있다. 오늘날 사람들은 사회활동의 증가, 환경오염에 따른 오존층 파괴로 인하여 유해 자외선에 장기 노출로 인한 멜라닌 침착 과다 현상으로 피부 흑화, 색소침착, 피부암 등 피부 건강뿐만 아니라 미적 측면에서도 크게 영향을 받고 있다. 특히 색소 침착과 같은 피부 흑화는 피부에 존재하는 멜라닌 합성이 원인이 되는 것으로 알려져 있다. 멜라닌은 멜라닌형성세포 내에 위치하는 멜라노좀에 의해 만들어지며 형성된 멜라닌은 각질형성세포로 이동하여 피부 상피층에 축적되어 색소침착 현상이 나타난다. 멜라닌 합성은 아미노산의 하나인 티로신을 기질로 티로시나아제에 의해 3,4-DOPA를 거쳐 DOPA 퀴논으로 전환되고 자동 산화반응과 효소반응으로 DOPA 크롬을 거쳐 흑갈색의 공동합체인 멜라닌이 생성하게 된다. 특히 효소인 티로시나아제는 멜라노사이트에서 멜라닌 색소의 합성에서 주요 핵심 효소로, 절대적으로 필요한 것으로 알려져 있고, 최근에는 이와 같은 효소를 억제하여 멜라닌 합성 저해를 위한 연구가 활발히 이루어지고 있다. 현재 알려진 합성 미백 원료들은 사용 중 분해나 착색, 이취 등으로 인해 불안정하여 안정성 문제 등이 대두되고 있다. 따라서 최근에는 세포에 영향을 미치지 않으며 멜라닌 합성을 감소시키는 천연 미백제에 대한 연구가 활발히 진행 중이다.When the skin is exposed to ultraviolet light, ET-1 (endothelin-1), corticotropin-releasing hormone (NO) and nitric oxide (NO) are secreted from the keratinocyte. The skin pigment is determined by the content of melanin produced by the melanin cells present in the basal layer. These melanin is a biopolymer substance widely present in nature and plays a role to prevent skin damage from ultraviolet rays or free radicals. Today, people are greatly affected not only by skin health but also by aesthetic aspects such as skin blackening, pigmentation and skin cancer due to excessive melanin deposition due to prolonged exposure to harmful ultraviolet rays due to an increase in social activities and ozone layer destruction due to environmental pollution. Skin darkening, especially pigmentation, is known to be caused by melanin synthesis in skin. Melanin is produced by melanomas located in melanocytes, and melanin formed is transferred to keratinocytes, accumulating in the epithelium of the skin, resulting in pigmentation. Melanin synthesis is converted to DOPA quinone by tyrosine as an amino acid, tyrosinase through 3,4-DOPA, and melanin is produced as a black brown complex through DOPA chromium by autoxidation and enzymatic reaction. In particular, tyrosinase, which is an enzyme, is known to be absolutely necessary as a key enzyme in the synthesis of melanin pigment in melanocytes. In recent years, studies for inhibiting melanin synthesis have been actively conducted by inhibiting such enzymes. Currently known synthetic whitening raw materials are unstable due to decomposition, coloring, and odor during use, leading to stability problems. Recently, studies on natural whitening agents that do not affect cells and reduce melanin synthesis are actively under way.
해양 생태계는 지구상에 존재하는 생물계의 95%를 차지하고 있으며 육상생물에 없는 특유의 대사과정과 독특한 환경으로 인하여 다양한 신규 생리활성물질의 탐색 가능성을 가지고 있다. 또한 육상생물은 이미 많은 연구가 진행되었지만, 해양생물은 고대로부터 내려오는 해양생물을 이용한 민간요법의 부재, 해양생물수집의 어려움 등의 이유로 제한된 연구만이 이루어져 앞으로 해양생물을 이용한 미지의 천연 물질의 개발에 대한 기대가 높이 평가되고 있다.The marine ecosystem occupies 95% of the world's biological systems and has the potential to explore a variety of new bioactive substances due to its unique metabolic processes and unique environment not found in terrestrial organisms. Although there have been many studies on terrestrial life, marine life has been limitedly studied due to the absence of folk therapy using ancient marine life and the difficulty of collecting marine life. Expectations for development are highly appreciated.
굴은 연체동물로 Eutaxodonta 목(order)의 굴(Ostreidae)과에 속하는 패류로서 세계적으로 100여 종 이상 알려져 있고, 우리나라 연안에는 참굴(Crassostrea gigas), 바윗굴(Crassostrea nippona), 벗굴(Ostrea denselamellosa) 등이 있다. 이중 우리나라에서 산업적으로 생산되고 있는 것은 참굴이다. 참굴은 둥근 형에서부터 가늘고 긴 형에 이르기까지 형태가 일정하지 않으나, 일반적으로 각고가 10 cm, 각장이 7 cm 정도이다. 동의보감에서는 굴은 숙취시 발생하는 갈증의 해소에 좋다고 명시되어 있으며, 오늘날에 이르러 굴의 다양한 영양적 가치도 보고되고 있다. 굴은 주로 단백질과 탄수화물로 구성되어 있으며, 그 중에서도 타우린(1,006 mg%)과 글리코겐의 함량이 높은 것으로 알려져 있다.Oyster is a mollusk and is known as a shellfish belonging to Ostreidae family of Eutaxodonta order. There are more than 100 kinds of shellfish in the world. In Korea, Crassostrea gigas , Crassostrea nippona , Ostrea denselamellosa ). Of these, the industrial production in Korea is oyster. The shape of the osuga is not uniform from round to thin and long, but generally it is 10 cm in length and 7 cm in length. In Donguibogam, oysters are said to be good for relieving thirst during hangover, and various nutritional values of oysters have been reported to this day. Oysters mainly consist of proteins and carbohydrates, among which taurine (1,006 mg%) and glycogen content are known to be high.
한국공개특허 제2008-0003277호에는 굴의 추출방법 및 굴 추출물을 함유하는 피부 미백용 화장료 조성물이 개시되어 있고, 한국공개특허 제2013-0015603호에는 굴 유래 펩타이드를 유효성분으로 포함하는 주름 개선용 화장료 조성물이 개시되어 있으나, 본 발명의 항산화 및 미백 활성이 증진된 굴 추출물의 제조방법과는 상이하다.Korean Patent Laid-Open Publication No. 2008-0003277 discloses an oyster extracting method and a cosmetic composition for skin whitening containing oyster extract. In Korean Patent Laid-Open Publication No. 2013-0015603, there is disclosed a composition for improving wrinkles containing an oyster- A cosmetic composition is disclosed, but is different from the oyster extract preparation method in which the antioxidative and whitening activity of the present invention is enhanced.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명의 목적은 항산화 활성 및 티로시나아제 저해 활성이 증진될 수 있는 조건으로 굴을 건조 및 추출하여 제조된 굴 추출물은 항산화 및 미백 활성이 증진될 뿐만 아니라, 저장안전성이 높아 화장품 등의 가공소재로 사용이 용이한 굴 추출물의 제조방법을 제공하는 데 있다.The object of the present invention is to provide an oyster extract which is prepared by drying and extracting oysters under the condition that antioxidative activity and tyrosinase inhibitory activity can be enhanced, The present invention also provides a method for producing oyster extract which is easy to use as a processing material for cosmetics and the like because of its high storage stability.
상기 과제를 해결하기 위해, 본 발명은 동결건조한 후 분쇄한 굴 분말을 메탄올로 추출하여 제조하는 것을 특징으로 하는 항산화 및 미백 활성이 증진된 굴 추출물의 제조방법을 제공한다.In order to solve the above problems, the present invention provides a method for producing an oyster extract in which antioxidative and whitening activity is enhanced by extracting oyster powder after freeze-drying and pulverization with methanol.
또한, 본 발명은 상기 방법으로 제조된 항산화 및 미백 활성이 증진된 굴 추출물을 제공한다.The present invention also provides an oyster extract produced by the above method and having enhanced antioxidative and whitening activity.
또한, 본 발명은 상기 굴 추출물을 유효성분으로 함유하는 미백용 화장료 조성물을 제공한다.The present invention also provides a whitening cosmetic composition comprising the oyster extract as an active ingredient.
본 발명의 방법으로 제조된 굴 추출물은 기존의 다른 방법으로 추출된 굴 추출물들에 비해 추출 수율이 증진될 뿐만 아니라, 굴 유래 기능성 성분들을 효율적으로 추출하여 항산화 활성 및 티로시나아제 저해 활성이 우수하여 항노화 및 미백에 효과적일 뿐만 아니라, 저장 안정성이 우수하여 다양한 화장품, 의약품 등의 가공소재로 적합한 굴 추출물을 제공할 수 있다.The oyster extract prepared by the method of the present invention not only enhances the extraction yield as compared with oyster extracts obtained by other conventional methods, but also efficiently extracts functional components derived from oysters and exhibits excellent antioxidative activity and tyrosinase inhibitory activity It is possible to provide an oyster extract which is effective for anti-aging and whitening, and is excellent in storage stability and suitable as a processing material for various cosmetics and medicines.
도 1은 굴 추출물을 함유하는 크림의 제조과정을 도식화한 것이다.
도 2는 굴 추출물의 농도별 DPPH 라디칼 소거능을 비교한 그래프이다.
도 3은 굴 추출물의 농도별 ABTS 라디칼 소거능을 비교한 그래프이다.
도 4는 굴 추출물의 티로시나아제 저해 활성을 비교한 그래프이다.
도 2 내지 4의 FOHW: 동결건조 굴 열수 추출물, HOHW: 열풍건조 굴 열수 추출물, FOE: 동결건조 굴 50% 에탄올 추출물, HOE: 열풍건조 굴 50% 에탄올 추출물, FOM: 동결건조 굴 50% 메탄올 추출물, HOM: 열풍건조 굴 50% 메탄올 추출물, AA: 아스코르브산을 의미한다.
도 5는 동결건조 굴 50% 메탄올 추출물을 함유한 크림을 25℃에서 저장하는 동안 변화를 비교한 사진이다.
(A) 저장 0일, (B) 저장 7일, (C) 저장 14일, (D) 저장 21일, (E) 저장 28일Figure 1 is a schematic representation of a process for making a cream containing oyster extract.
2 is a graph comparing the DPPH radical scavenging ability of oyster extracts according to their concentrations.
FIG. 3 is a graph comparing the ABTS radical scavenging ability of oyster extracts according to their concentrations.
Fig. 4 is a graph comparing tyrosinase inhibitory activities of oyster extracts.
50% ethanol extract of freeze-dried oyster, HOE: 50% ethanol extract of hot-air dried oyster, FOM: 50% methanol extract of freeze-dried oyster extracts of FOHW: freeze-dried oyster hot water extracts of FIGS. 2 to 4, HOHW: hot air dried oyster hot water extract, FOE: , HOM: 50% methanol extract of hot-air dried oyster, and AA: ascorbic acid.
FIG. 5 is a photograph comparing the changes during storage of the cream containing the 50% methanol extract of freeze-dried oyster at 25 占 폚.
(A) Save 0 days, (B) Save 7 days, (C) Save 14 days, (D) Save 21 days,
본 발명의 목적을 달성하기 위하여, 본 발명은 동결건조한 후 분쇄한 굴 분말을 메탄올로 추출하여 제조하는 것을 특징으로 하는 항산화 및 미백 활성이 증진된 굴 추출물의 제조방법을 제공한다.In order to accomplish the object of the present invention, the present invention provides a method for preparing oyster extract having enhanced antioxidant and whitening activity, characterized in that the oyster powder obtained by freeze-drying and then pulverized is extracted with methanol.
본 발명의 굴 추출물의 제조방법에서, 상기 동결건조는 바람직하게는 -50~-70℃에서 44~52시간 동안 실시할 수 있으며, 더욱 바람직하게는 -60℃에서 48시간 동안 실시할 수 있다. 상기와 같은 조건으로 동결건조한 굴을 추출하는 것이 굴의 기능성 물질을 효율적으로 추출하여 항산화 및 티로시나아제 저해 활성이 우수한 추출물로 제조할 수 있었다.In the method for producing oyster extract of the present invention, the freeze-drying can be carried out preferably at -50 to -70 캜 for 44 to 52 hours, more preferably at -60 캜 for 48 hours. The extraction of freeze-dried oysters under the above conditions efficiently extracted functional materials of oysters, and thus it was possible to prepare extracts having excellent antioxidant and tyrosinase inhibiting activity.
또한, 본 발명의 굴 추출물의 제조방법에서, 상기 추출은 바람직하게는 굴 분말에 40~60%(v/v) 메탄올을 0.8~1.2:16~24 중량비로 첨가한 후 20~30℃에서 20~28시간 동안 추출할 수 있으며, 더욱 바람직하게는 굴 분말에 50%(v/v) 메탄올을 1:20 중량비로 첨가한 후 25℃에서 24시간 동안 추출할 수 있다. 상기와 같은 조건으로 추출된 굴 추출물은 저장안전성이 증진되면서 품질이 양호하여 가공소재로 활용이 적당할 뿐만 아니라, 항산화 및 미백 활성이 증진되어 기능성 소재로 활용이 우수한 추출물로 제조할 수 있었다.In addition, in the method for producing an oyster extract of the present invention, the extraction is preferably performed by adding 40 to 60% (v / v) methanol to the oyster powder at a weight ratio of 0.8 to 1.2: 16 to 24, (V / v) methanol may be added to the oyster powder at a weight ratio of 1:20, followed by extraction at 25 ° C for 24 hours. The oyster extracts extracted under the above conditions were improved in storage stability and thus, they were suitable for use as processing materials, and antioxidative and whitening activities were improved. Thus, the extract could be used as a functional material.
본 발명의 굴 추출물의 제조방법은, 보다 구체적으로는 -50~-70℃에서 44~52시간 동안 동결건조한 후 분쇄한 굴 분말에 40~60%(v/v) 메탄올을 0.8~1.2:16~24 중량비로 첨가한 후 20~30℃에서 20~28시간 동안 추출하여 제조할 수 있으며, 더욱 구체적으로는 -60℃에서 48시간 동안 동결건조한 후 분쇄한 굴 분말에 50%(v/v) 메탄올을 1:20 중량비로 첨가한 후 25℃에서 24시간 동안 추출하여 제조할 수 있다.More specifically, the oyster extract of the present invention is prepared by lyophilizing the oyster powder at -50 to -70 ° C for 44 to 52 hours, adding 40 to 60% (v / v) methanol to the oyster powder at a ratio of 0.8 to 1.2: (V / v) is added to the oyster powder after the freeze-drying at -60 ° C for 48 hours, and then the oyster powder is added to the oyster powder at 20 to 30 ° C for 20 to 28 hours. Methanol at a weight ratio of 1:20 and then extraction at 25 ° C for 24 hours.
본 발명은 또한, 상기 방법으로 제조된 항산화 및 미백 활성이 증진된 굴 추출물을 제공한다.The present invention also provides an oyster extract with enhanced antioxidant and whitening activity, prepared by the above method.
본 발명은 또한, 상기 굴 추출물을 유효성분으로 함유하는 미백용 화장료 조성물을 제공한다. 상기 화장료는 스킨, 스킨 소프트너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 마사지크림, 영양크림, 아이 크림, 모이스쳐 크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징 폼, 클렌징 워터, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 비누 및 파우더로 이루어진 군으로부터 선택되는 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다.The present invention also provides a whitening cosmetic composition comprising the oyster extract as an active ingredient. The cosmetic may be at least one selected from the group consisting of a skin, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrient lotion, a massage cream, a nutrition cream, an eye cream, a moisturizer cream, a hand cream, But are not limited to, any one of the formulations selected from the group consisting of cleansing water, cleansing lotion, cleansing cream, body lotion, body cleanser, soap and powder.
또한, 상기 미백용 화장료는 본 발명의 굴 추출물에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.
In addition, the whitening cosmetic composition may further contain, in addition to the oyster extract of the present invention, a lipid, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, , Water, ionic or nonionic emulsifiers, fillers, sequestering agents and chelating agents, preservatives, vitamins, barrier agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics And may contain adjuvants conventionally used in the cosmetics field, such as any other ingredients used.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시 예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시 예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
1. 재료 및 제조방법1. Materials and manufacturing methods
(1) 재료(1) Material
본 실험에서 사용한 굴은 경남 통영시 소재 수산업협동조합 공판장에서 구입하였다. 굴은 세척한 다음 동결건조와 열풍건조 방법으로 건조한 다음 분쇄기로 분쇄하여 분말화하였고, -70℃의 냉동 냉장고(deep freezer)에 보관하면서 분석용 시료로 사용하였다. 상기 동결건조는 동결건조기를 이용하여 -60℃에서 48시간 동안 건조하였고, 상기 열풍건조는 열풍건조기를 이용하여 40℃에서 48시간 동안 건조하였다.
The oysters used in this study were purchased from the cooperative headquarters of Fisheries Cooperative in Tongyeong, Gyeongnam Province. The oysters were washed and then dried by lyophilization and hot air drying, pulverized by a pulverizer, powdered and stored in a deep freezer at -70 ° C for analysis. The lyophilization was performed using a freeze dryer at -60 ° C for 48 hours, and the hot air drying was performed at 40 ° C for 48 hours using a hot air dryer.
(2) 굴 추출물 제조(2) Production of Oyster Extract
추출물 제조는 굴 건조분말 15 g에 300 mL의 용매(50% 메탄올, 50% 에탄올, 증류수)를 각각 가하여 진탕 배양기를 이용하여 25℃에서 24시간 동안 추출하였다. 각각의 추출 시료는 여과지(Whatman No.1)로 여과한 다음, 37℃에서 회전진공농축기로 농축하고 동결건조하여 분석용 시료로 사용하였다.
Extracts were prepared by adding 300 mL of a solvent (50% methanol, 50% ethanol, distilled water) to 15 g of oyster powder and extracting them at 25 ° C for 24 hours using a shaking incubator. Each extract was filtered with a filter paper (Whatman No. 1), concentrated at 37 ° C in a rotary vacuum concentrator, and lyophilized to use as an analytical sample.
2. 굴 추출물의 실험방법2. Experimental method of oyster extract
(1) 추출 수율(1) extraction yield
추출 수율은 건조오븐(Forced convection oven, Jeico Tech, Korea)을 이용하여 105℃ 상압가열건조법으로 항량이 될 때까지 건조한 후 추출물 제조에 사용한 원료 건물량에 대한 고형분 함량으로 나타내었다.
The extraction yield was expressed as the solid content with respect to the amount of raw material used for the preparation of the extract after drying until constant weight by heating at 105 ° C using a drying oven (Forced convection oven, Jeico Tech, Korea).
(2) 총당 함량 측정(2) Measurement of total sugar content
총당 함량은 시료 1 mL에 5% 페놀(phenol) 용액 1 mL를 넣고 혼합한 다음, 황산(H2SO4) 5 mL를 천천히 가하여 20분 동안 상온방치하여 470 nm에서 흡광도를 측정하였다. 총당 함량은 글루코스(glucose)를 표준물질로 사용하여 표준 곡선으로 계산하였다.
The total sugar content was obtained by adding 1 mL of 5% phenol solution to 1 mL of the sample, adding 5 mL of sulfuric acid (H 2 SO 4 ) slowly to the solution, and allowing the solution to stand at room temperature for 20 minutes. Total sugar content was calculated as a standard curve using glucose as a standard.
(3) 총 단백질 함량 측정(3) Measurement of total protein content
총 단백질 함량은 BSA(bovine serum albumin, Sigma Chem, Co., St Louis, MO, USA)를 표준품으로 한 표준곡선에 의하여 함량을 계산하였다.
The total protein content was calculated by standard curve with BSA (bovine serum albumin, Sigma Chem, Co., St Louis, MO, USA) as a standard.
(4) DPPH 라디칼 소거능 측정(4) Measurement of DPPH radical scavenging ability
DPPH 라디칼 소거능은 DPPH(1,1 diphenyl-2-picrylhydrazyl)의 환원력을 이용하여 측정하였다. 시료를 DMSO로 희석하여 최종농도가 1,000, 5,000, 10,000 ㎍/mL이 되도록 정량하여 농도별 시료 0.5 mL에 DPPH 용액 5 mL를 가한 후 상온에서 15분간 반응시켜 517 nm에서 흡광도를 측정하였다. 대조구는 시료 대신 0.5 mL의 증류수를 사용하였으며, 블랭크(blank) 시험은 DPPH 용액 대신 5 mL의 증류수를 사용하였다. 대조군으로는 아스코르브산(ascorbic acid)을 사용하였으며, 각 시료의 라디칼 소거능은 아래의 식에 의해 라디칼 소거능으로 계산하여 백분율로 나타내었다.The DPPH radical scavenging activity was measured using the reducing power of DPPH (1,1 diphenyl-2-picrylhydrazyl). The samples were diluted with DMSO to a final concentration of 1,000, 5,000, and 10,000 μg / mL. 5 mL of DPPH solution was added to 0.5 mL of each sample at a concentration, and the reaction was carried out at room temperature for 15 minutes to measure the absorbance at 517 nm. For the control, 0.5 mL of distilled water was used instead of the sample. For the blank test, 5 mL of distilled water was used instead of the DPPH solution. As a control group, ascorbic acid was used. The radical scavenging activity of each sample was calculated as a percentage by radical scavenging ability according to the following equation.
DPPH 라디칼 소거능(%) = [1-(샘플 흡광도/대조구 흡광도)]×100
DPPH radical scavenging activity (%) = [1- (sample absorbance / control absorbance)] × 100
(5) ABTS 라디칼 소거능 측정(5) Measurement of ABTS radical scavenging ability
7.4 nM ABTS[2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt]와 2.6 nM 과황화칼륨(potassim persulfate)을 혼합하여 실온 암소에서 24시간 동안 방치하여 라디칼을 형성시킨 다음 실험 직전에 증류수와 1:17(v/v) 비율로 섞어 732 nm에서의 흡광도 값이 약 1.2가 되도록 조절한 ABTS 용액을 사용하였다. ABTS 용액 980 ㎕에 DMSO에 녹인 굴 추출물 분말(1,000, 5,000, 10,000 ㎍/mL) 50 ㎕를 가하여 10분간 반응시킨 후 732 nm에서 흡광도를 측정하였다.
7.4 nM ABTS [2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt] was mixed with 2.6 nM potassium persulfate and allowed to stand in a dark room for 24 hours to form radicals Immediately before the next experiment, ABTS solution was used, which was mixed with distilled water at a ratio of 1: 17 (v / v) and adjusted to an absorbance value of about 1.2 at 732 nm. To 980 μl of ABTS solution, 50 μl of oyster powder (1,000, 5,000, 10,000 ㎍ / ml) dissolved in DMSO was added and incubated for 10 minutes. Absorbance was measured at 732 nm.
(6) 티로시나아제(tyrosinase) 저해 활성 측정(6) Measurement of inhibitory activity of tyrosinase
반응구는 0.175M 인산완충액(pH 6.8) 0.5 mL에 10 mM L-DOPA를 녹인 기질액 0.2 mL와 시료용액 0.1 mL의 혼합액에 머쉬룸 티로시나아제(110U/mL) 0.2 mL를 첨가하여 37℃에서 3분간 반응시켜 반응액 중에 생성된 DOPA chrome을 475 nm에서 측정하였다. 티로시나아제 저해활성은 시료용액의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다.
To the reaction mixture, 0.2 mL of mushroom tyrosinase (110 U / mL) was added to a mixture of 0.2 mL of the substrate solution in which 10 mM L-DOPA had been dissolved and 0.1 mL of the sample solution in 0.5 mL of 0.175 M phosphate buffer (pH 6.8) And the DOPA chrome produced in the reaction solution was measured at 475 nm. The inhibitory activity of tyrosinase was expressed by the absorbance reduction rate of the addition of the sample solution and the non-addition of the sample solution.
3. 굴 추출물을 함유하는 크림의 저장안정성 평가3. Evaluation of storage stability of cream containing oyster extract
(1) 굴 추출물을 첨가한 크림 제조(1) Cream production with oyster extract
크림 제조는 표 1의 레시피에 따라 제조하였으며, 제조과정은 도 1과 같다. 즉, 지용성 물질인 파트 A를 75℃에서 완전히 녹인 다음 수용성 물질인 파트 B를 서서히 넣어주면서 75℃에서 완전히 용해시켰다. 그리고 파트 A와 B 혼합액에 추출방법에 따른 동결건조 굴 메탄올 추출물이 함유되어 있는 파트 C를 서서히 넣어주면서 균질화 하였다.The preparation of the cream was made according to the recipe of Table 1, and the manufacturing process is as shown in Fig. That is, Part A, which is a lipid-soluble substance, was completely dissolved at 75 ° C and completely dissolved at 75 ° C while gradually adding Part B, which is a water-soluble substance. Part C, containing the freeze-dried oyster methanol extract according to the extraction method, was gradually added to the mixture of Part A and B and homogenized.
(2) 색도 측정(2) Chromaticity measurement
색도의 측정은 Hunter color difference meter(Chromameter CR200, Minolta Co, Japan)를 사용하여 4주 동안 0℃, 25℃ 및 40℃에서 1주 간격으로 L값(lightness), a값(redness), b값(yellowness)을 측정하였다.
The chromaticity was measured by using a Hunter color difference meter (Chromameter CR200, Minolta Co, Japan) for 4 weeks at 0 ° C, 25 ° C and 40 ° C at 1 week intervals with L value (lightness) (yellowness) were measured.
(3) pH 측정(3) pH measurement
추출용매에 따른 굴 추출물을 첨가한 미백크림을 화장품 보관 용기에 넣은 후, 4주 동안 0℃, 25℃ 및 40℃에서 1주 간격으로 pH 안정성을 측정하였다.
The whitening cream added with oyster extract according to the extraction solvent was placed in a cosmetic container, and the pH stability was measured at 0 ° C, 25 ° C and 40 ° C for four weeks at intervals of one week.
(4) 변색 및 변취 관찰(4) Discoloration and detachment observation
추출용매에 따른 굴 추출물을 첨가한 미백 크림을 화장품 보관 용기에 넣은 후, 4주 동안 0℃, 25℃ 및 40℃에서 1주 간격으로 저장안정성을 평가하기 위하여 육안으로 층분리 및 응집 여부, 변색 및 변취 등을 검토하였다.
In order to evaluate the storage stability at 0 ℃, 25 ℃ and 40 ℃ for 4 weeks at 1 week intervals, the whitening cream added with oyster extract according to the extraction solvent was put into a cosmetic storage container. And the like.
실시예Example 1: 굴 추출물의 추출 수율 1: Extraction yield of oyster extract
건조 방법 및 추출용매에 따른 굴 추출물의 수율을 표 2에 나타내었다. 동결건조된 굴의 추출 수율이 열풍건조 조건보다 양호하였으며 추출용매에 따른 수율은 동결건조 굴 메탄올 추출물이 19.75%로 가장 우수하였다. 열풍건조의 경우 메탄올 추출물이 18.12%로 가장 높았고 열수 추출물이 10.73%로 가장 낮음을 알 수 있었다. 천연 추출물의 항산화 활성이 높게 인정된다 하더라도 추출 수율이 낮으면 경제성이 없는데, 본 추출물에서는 대략 10.73~19.75%의 추출 수율을 보여주어 산업적으로 경제성을 고려하였을 때 기능성 소재로서의 활용 가능성은 있다고 사료된다.Table 2 shows the yield of oyster extracts according to the drying method and the extraction solvent. The extraction yield of lyophilized oyster was better than that of hot - air drying. The yield of lyophilized oyster extract was the highest at 19.75%. In the case of hot air drying, the methanol extract was the highest at 18.12% and the hot water extract was the lowest at 10.73%. Although the extraction yield of the natural extract is high, it is not economical if the extraction yield is low. The extraction yield of this extract is about 10.73 ~ 19.75%, which is considered to be useful as a functional material when considering the economical efficiency in industry.
실시예Example 2: 굴 추출물의 총당 및 총 단백질 함량 2: total sugar and total protein content of oyster extract
건조방법 및 추출용매에 따른 굴 추출물의 총당 및 총 단백질 함량을 분석한 결과는 표 3과 같다. 총당 함량은 동결건조 굴 추출물이 7.554~21.771% 였으며, 열풍건조 굴 추출물에서 6.322~21.877%로 나타났다. 단백질 함량은 동결건조 굴 추출물이 3.459~13.372%로 열풍건조 굴 추출물보다 높은 함량을 보였다. 추출용매에 따른 총당 및 총 단백질 함량은 열수 추출물이 메탄올 및 에탄올 추출물에 비해 높은 함량을 나타내었다.Table 3 shows the results of analysis of total sugar and total protein content of oyster extracts according to the drying method and the extraction solvent. Total sugar contents of freeze - dried oyster extracts were 7.554 ~ 21.771% and those of hot - air oyster extracts were 6.322 ~ 21.877%. The protein content of freeze - dried oyster extract was 3.459 ~ 13.372% higher than that of hot - air oyster oyster extract. Total sugars and total protein contents of the extracts were higher than those of methanol and ethanol extracts.
실시예Example 3: 굴 추출물의 3: oyster extract DPPHDPPH 라디칼Radical 소거능Scatters
DPPH 라디칼 소거능은 활성 라디칼에 전자를 공여하여 지방질 산화를 억제시키는 척도로 사용되고 있을 뿐만 아니라 인체 내에서 활성 라디칼에 의한 노화를 억제하는 작용의 척도로도 이용되고 있다. 건조방법 및 추출용매에 따른 DPPH 라디칼 소거능의 분석 결과는 도 2와 같다. 동결건조 굴 추출물이 열풍건조 굴 추출물에 비해 DPPH 라디칼 소거능이 양호함을 확인하였는데, 모든 추출물이 1,000~10,000 ㎍/mL에서 농도가 증가함에 따라 증가하였다. 추출 용매별 DPPH 라디칼 소거능은 메탄올 및 에탄올 추출물이 열수 추출물에 비해 우수하였으며, 특히 동결건조된 메탄올 추출물이 다른 건조조건 및 추출조건에 비해 항산화 활성이 우수함을 확인하였다.
DPPH radical scavenging activity is used not only as a measure to inhibit lipid oxidation by donating electrons to active radicals but also as a measure of inhibiting aging by active radicals in the human body. The results of analysis of the DPPH radical scavenging ability according to the drying method and the extraction solvent are shown in FIG. The freeze - dried oyster extracts showed better DPPH radical scavenging ability than the hot - air dried oyster extracts. All extracts increased with increasing concentration at 1,000 ~ 10,000 ㎍ / mL. The DPPH radical scavenging activity of the extracts was better than that of the hot - water extracts. Especially, the freeze - dried methanol extracts showed higher antioxidant activity than the other dry and extraction conditions.
실시예Example 4: 굴 추출물의 4: oyster extract ABTSABTS 라디칼Radical 소거능Scatters
건조방법 및 추출조건에 따른 굴 추출물의 ABTS 라디칼 소거능은 도 3과 같다. 전반적으로 동결건조 굴 추출물의 ABTS 라디칼 소거능이 우수하였으며, 시료 농도가 증가함에 따라 증가하는 경향이었다. 추출 용매별로 비교하였을 때, 동결건조 50% 메탄올 추출물이 1,000, 5,000, 10,000 ㎍/mL에서 각각 8.9%, 39%, 45%로 다른 추출방법에 비해 가장 높은 항산화 활성을 보여주었다.
The ABTS radical scavenging ability of the oyster extract according to the drying method and the extraction conditions is shown in FIG. Overall, the free radical scavenging ability of ABTS radical scavenging ability was excellent and increased with increasing sample concentration. Compared with other extraction methods, 50% methanol extract of lyophilized extract showed the highest antioxidative activity at 1,000, 5,000, and 10,000 ㎍ / mL, respectively.
실시예Example 5: 굴 추출물의 티로시나아제 저해 활성 측정 5: Measurement of tyrosinase inhibitory activity of oyster extract
티로시나아제는 피부가 자외선에 노출되면 티로신에서 멜라닌 생성에 가장 중요하게 작용하는 효소로써 티로시나아제 활성을 저해함으로써 멜라닌 생성을 억제할 수 있으며, 이로 인해 기미, 주근깨, 노인성 홍반 등의 유발을 막을 수 있는 것으로 알려져 있다. 굴 추출물의 티로시나아제 저해 활성 측정 결과는 도 4와 같다. 건조조건에서는 동결건조 추출물이 열풍건조 추출물에 비해 티로시나아제 저해활성이 우수하였으며, 추출 용매별로는 메탄올, 에탄올 및 열수 추출물 순으로 저해활성이 높았다. 티로시나아제 저해활성을 1,000 ㎍/mL의 농도에서 비교하였을 때, 동결건조 및 열풍건조에서 열수 추출물은 각각 68%, 52%의 저해 활성을 보였으며, 에탄올 추출물이 67%, 63%의 저해활성이 나타내었고, 메탄올 추출물은 81%, 73%의 저해 활성을 나타내었다.
Tyrosinase is an enzyme that plays an important role in the production of melanin in tyrosine when skin is exposed to ultraviolet light. It inhibits tyrosinase activity, thereby inhibiting melanin production. As a result, it prevents the occurrence of spots, freckles, and erythema It is known to be able to. The result of measuring tyrosinase inhibitory activity of oyster extract is shown in Fig. In the dry condition, the freeze - dried extract showed better inhibitory activity against tyrosinase than the hot - air dried extract. Methanol, ethanol and hot - water extract showed higher inhibitory activity in the order of extraction solvent. When the tyrosinase inhibitory activity was compared at the concentration of 1,000 ㎍ / mL, the hot water extracts showed inhibitory activity of 68% and 52% in the freeze drying and hot air drying, respectively. Ethanol extract showed inhibition activity of 67% and 63% And methanol extract showed inhibition activity of 81% and 73%, respectively.
실시예Example 6: 굴 추출물을 함유한 크림의 색도 6: Color of cream containing oyster extract
표 1의 배합비로 배합하여 제조된 굴 추출물을 함유한 크림을 화장품 보관 용기에 보관하면서 색도를 측정한 결과는 표 4 내지 6에 나타내었다. 전반적으로 모든 조건에서 저장 온도와 기간에 따른 특이적 변화는 관찰되지 않았는데, 화장품의 원료 성분과 굴 추출물의 색이 황색 계열이기 때문에 a값은 낮게 분석되었고, 황색도를 나타내는 b값은 a값에 비해 높은 값을 보였다.The cream containing the oyster extract prepared by blending at the compounding ratio shown in Table 1 was stored in a cosmetic container and the chromaticity was measured. The results are shown in Tables 4 to 6. As a result, there was no specific change depending on storage temperature and duration. In all the conditions, the a value was low and the b value indicating yellowness was a value Respectively.
L값의 경우 굴 추출물을 넣지 않은 크림이 가장 높은 것을 확인할 수 있었고, 굴 추출물 첨가구의 경우 소재 자체의 색으로 인해 L값이 전반적으로 낮았다. 굴 추출물을 첨가한 크림의 경우 낮은 온도에서 보관할수록 L값이 증가하는 경향을 보였으며, 반대로 굴을 첨가한 크림의 경우에는 감소하는 경향을 나타내었다. 적색을 나타내는 a값의 경우, 굴 추출물을 첨가하지 않은 크림보다 첨가한 크림의 a값이 더 낮아지는 경향을 보였으며, 전반적으로 저장 온도가 높아짐에 따라 증가하였다. The L value of the oyster extract was higher than that of the oyster extract. In the case of the cream containing oyster extract, the L value tended to increase with storage at low temperature. On the other hand, the cream with oyster tended to decrease. The a value of the red color showed a tendency to lower the a value of the added cream than that of the cream not containing the oyster extract and increased with the increase of the storage temperature as a whole.
b값의 경우, 굴 추출물을 첨가한 크림은 추출용매 모두에서 동결건조 처리한 굴이 열풍건조 구간에 비해 높은 값을 보여주었다. 또한, 저장 온도와 저장 기간에 따라 b값의 변화는 큰 차이를 보여주지 않았다. 따라서, 굴 추출물을 첨가한 크림은 저장 온도 및 기간에 따라 색도의 변화가 일정한 관계로 향후 제품 적용시 안정할 것으로 판단되었다.In the case of b value, the cream containing oyster extract showed higher value than the freeze - dried oyster in the hot - air drying section in all the extraction solvents. The change of b value did not show a significant difference according to storage temperature and storage period. Therefore, it was concluded that the cream containing oyster extracts would be stable when the product was applied in the future since the change of chromaticity was constant depending on storage temperature and period.
FOHW: 동결건조 굴 열수 추출물을 함유한 크림, HOHW: 열풍건조 굴 열수 추출물을 함유한 크림, FOE: 동결건조 굴 50% 에탄올 추출물을 함유한 크림, HOE: 열풍건조 굴 50% 에탄올 추출물을 함유한 크림, FOM: 동결건조 굴 50% 메탄올 추출물을 함유한 크림, HOM: 열풍건조 굴 50% 메탄올 추출물을 함유한 크림, NO: 굴 추출물을 함유하지 않은 크림FOHW: Cream containing freeze-dried oyster hydrothermal extract, HOHW: Cream containing hot-air oyster hydrothermal extract, FOE: Cream containing 50% ethanol extract of freeze-dried oyster, HOE: Cream, FOM: Cream containing 50% methanol extract of freeze-dried oyster, HOM: Cream containing 50% methanol extract of hot-air oyster, NO: Cream containing oyster extract
FOHW: 동결건조 굴 열수 추출물을 함유한 크림, HOHW: 열풍건조 굴 열수 추출물을 함유한 크림, FOE: 동결건조 굴 50% 에탄올 추출물을 함유한 크림, HOE: 열풍건조 굴 50% 에탄올 추출물을 함유한 크림, FOM: 동결건조 굴 50% 메탄올 추출물을 함유한 크림, HOM: 열풍건조 굴 50% 메탄올 추출물을 함유한 크림, NO: 굴 추출물을 함유하지 않은 크림FOHW: Cream containing freeze-dried oyster hydrothermal extract, HOHW: Cream containing hot-air oyster hydrothermal extract, FOE: Cream containing 50% ethanol extract of freeze-dried oyster, HOE: Cream, FOM: Cream containing 50% methanol extract of freeze-dried oyster, HOM: Cream containing 50% methanol extract of hot-air oyster, NO: Cream containing oyster extract
FOHW: 동결건조 굴 열수 추출물을 함유한 크림, HOHW: 열풍건조 굴 열수 추출물을 함유한 크림, FOE: 동결건조 굴 50% 에탄올 추출물을 함유한 크림, HOE: 열풍건조 굴 50% 에탄올 추출물을 함유한 크림, FOM: 동결건조 굴 50% 메탄올 추출물을 함유한 크림, HOM: 열풍건조 굴 50% 메탄올 추출물을 함유한 크림, NO: 굴 추출물을 함유하지 않은 크림
FOHW: Cream containing freeze-dried oyster hydrothermal extract, HOHW: Cream containing hot-air oyster hydrothermal extract, FOE: Cream containing 50% ethanol extract of freeze-dried oyster, HOE: Cream, FOM: Cream containing 50% methanol extract of freeze-dried oyster, HOM: Cream containing 50% methanol extract of hot-air oyster, NO: Cream containing oyster extract
실시예Example 7: 굴 추출물을 함유한 크림의 7: Cream containing oyster extract pHpH
굴 추출물을 함유한 크림의 pH 안정성을 저장온도 및 저장기간에 따라 관찰한 결과는 하기 표 7과 같다. 분석결과 pH는 5.17~5.80 범위를 나타내었으며 건조방법 및 추출용매에 따라 저장온도 및 기간별 차이는 발견되지 않았으나 전반적으로 저장 온도가 증가함에 따라 pH도 증가하는 경향이었다. 저장기간이 증가함에 따라 pH는 점진적으로 낮아지는 경향이었으나 그 차이가 크지 않아 안정함을 확인하였다.The pH stability of the cream containing the oyster extract was observed according to the storage temperature and storage period, as shown in Table 7 below. As a result, pH was in the range of 5.17 ~ 5.80. The difference of storage temperature and period was not found according to the drying method and extraction solvent, but the pH tended to increase as the storage temperature increased. As the storage period increased, the pH tended to gradually decrease, but the difference was not significant and it was confirmed to be stable.
정상 각질층에서의 표면 산성도는 피부 표면의 진균 및 세균을 억제하기 위해 pH 5.0~5.5 범위이다. 굴 추출물을 첨가한 크림의 pH는 모두 피부의 조건과 유사한 pH 값을 보여주어 화장품 제조용 소재로 활용 가능함을 확인하였다.The surface acidity in the normal horny layer is in the range of 5.0 to 5.5 to inhibit fungi and bacteria on the surface of the skin. The pH of the cream containing oyster extract showed a pH value similar to that of skin, confirming that it could be used as a material for cosmetic production.
FOHW: 동결건조 굴 열수 추출물을 함유한 크림, HOHW: 열풍건조 굴 열수 추출물을 함유한 크림, FOE: 동결건조 굴 50% 에탄올 추출물을 함유한 크림, HOE: 열풍건조 굴 50% 에탄올 추출물을 함유한 크림, FOM: 동결건조 굴 50% 메탄올 추출물을 함유한 크림, HOM: 열풍건조 굴 50% 메탄올 추출물을 함유한 크림, NO: 굴 추출물을 함유하지 않은 크림
FOHW: Cream containing freeze-dried oyster hydrothermal extract, HOHW: Cream containing hot-air oyster hydrothermal extract, FOE: Cream containing 50% ethanol extract of freeze-dried oyster, HOE: Cream, FOM: Cream containing 50% methanol extract of freeze-dried oyster, HOM: Cream containing 50% methanol extract of hot-air oyster, NO: Cream containing oyster extract
실시예Example 8: 굴 추출물을 함유한 크림의 변색 및 8: discoloration of cream containing oyster extract and 변취Fling 관찰 observe
굴 추출물을 함유한 미백크림의 25℃에서 저장기간에 따른 안정성을 육안으로 층 분리 및 응집 여부, 변색 및 변취 등을 관찰한 결과, 크리밍이나 응집과 같은 분리 현상이 관찰되지 않았으며, 산화에 의한 특이취도 관찰되지 않았다. 이를 통해 굴 추출물을 첨가한 크림 이외 다양한 화장품 제조용 소재로 활용 가능함을 알 수 있었다(도 5).The stability of the whitening cream containing oyster extracts at 25 ℃ was investigated by layering, coagulation, discoloration and removal by visual observation. As a result, separation phenomena such as creaming and aggregation were not observed. No specific odds were observed. As a result, it could be used as a material for manufacturing various cosmetics other than cream added with oyster extract (FIG. 5).
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130165789A KR101552472B1 (en) | 2013-12-27 | 2013-12-27 | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130165789A KR101552472B1 (en) | 2013-12-27 | 2013-12-27 | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150076999A true KR20150076999A (en) | 2015-07-07 |
KR101552472B1 KR101552472B1 (en) | 2015-09-11 |
Family
ID=53789847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130165789A Active KR101552472B1 (en) | 2013-12-27 | 2013-12-27 | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101552472B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190067442A (en) * | 2017-12-07 | 2019-06-17 | 주식회사 선마린바이오테크 | Cosmetic composition comprising oysters, sea cucumber, sea squirt, Aplysia kurodai and buccinum striatissimum |
KR101998804B1 (en) | 2019-03-05 | 2019-07-10 | 에스앤에프 주식회사 | Antioxidant and anti-aging composition |
KR20200106633A (en) | 2019-03-05 | 2020-09-15 | 에스앤에프 주식회사 | Process for preparing antioxidant and anti-aging composition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240133168A (en) | 2023-02-28 | 2024-09-04 | 건국대학교 글로컬산학협력단 | Composition for protecting against alcohol-induced colon and liver damage containing lactic acid bacteria fermentation of Crassostrea gigas extract |
KR20250097608A (en) | 2023-12-20 | 2025-06-30 | 신라대학교 산학협력단 | Fermented Crassostrea gigas with enhanced anti-oxidant, anti-inflammation and anti-diabetic activities, and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013192514A (en) * | 2012-03-21 | 2013-09-30 | Lion Corp | Method for manufacturing oyster extract |
-
2013
- 2013-12-27 KR KR1020130165789A patent/KR101552472B1/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190067442A (en) * | 2017-12-07 | 2019-06-17 | 주식회사 선마린바이오테크 | Cosmetic composition comprising oysters, sea cucumber, sea squirt, Aplysia kurodai and buccinum striatissimum |
KR101998804B1 (en) | 2019-03-05 | 2019-07-10 | 에스앤에프 주식회사 | Antioxidant and anti-aging composition |
KR20200106633A (en) | 2019-03-05 | 2020-09-15 | 에스앤에프 주식회사 | Process for preparing antioxidant and anti-aging composition |
Also Published As
Publication number | Publication date |
---|---|
KR101552472B1 (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060233738A1 (en) | Composition for promoting production of type 1 collagen and/or elastin | |
KR101704874B1 (en) | Cosmetic Compositions with Whitening and Anti-oxidative Effect Comprising of Phragmitis Rhizoma, Salicomia herbacea L. and Prunus mume | |
KR101360760B1 (en) | Fermented ear shell extract and its cosmetic usage | |
KR101552472B1 (en) | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity | |
KR20140016461A (en) | Fermented sea cucumber extract and its cosmetic usage | |
CN113631227B (en) | Anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and cosmetics | |
KR102432749B1 (en) | Cosmetic composition containing Pteridium aquilinum exosome | |
KR101475454B1 (en) | A Cosmetic Composition for Improving Skin Cell Growth, Skin Wrinkle, Collagen Synthesis and Skin Moisturizing Containing The Extract of starfish and Ulmus davidiana var. japonica | |
KR101437997B1 (en) | Fermented caviar extract and its cosmetic usage | |
KR20200083098A (en) | Cosmetic composition with liposome including acerola extract | |
CN112137919B (en) | Application of dictyophora indusiata egg extract in preparation of external beauty and skin care products and external beauty and skin care products based on same | |
KR20140025239A (en) | Cosmetic composition containing active fractions of rubus coreanus miq root | |
KR101904215B1 (en) | A composition for antioxidating and blocking ultraviolet comprising extracts of jujube seed | |
KR102075849B1 (en) | Composition for skin moisturizing and anti-inflammation and enhancing skin barrier comprising Aureobasidium pullulans extract as effective component | |
KR101954275B1 (en) | Cosmetic compositions containing complex extract of gold kiwi peel and dragon fruit peel, and method manufacturing the same | |
KR101863053B1 (en) | Composition with the extract of roasted Schisandra chinensis for improvement of skin wrinkle | |
KR102487634B1 (en) | A cosmetic composition containing eisenia bicyclis extract for skin whitening and wrinkle treatment, and manufacturing method thereof | |
CN118695846A (en) | Process for obtaining plant extracts comprising a self-fermentation step, compositions comprising such extracts and their cosmetic use | |
WO2014128126A2 (en) | Cosmetic use of queuine | |
KR102175244B1 (en) | antioxidant composition comprising Astragalus membranaceus and method of manufacturing the same | |
KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract | |
CN113905717A (en) | Natural skin care compositions and methods for treating oxidative stress and restoring skin health | |
KR102803251B1 (en) | Composition for improving skin conditions comprising the extract of Allium ulleungense | |
KR102630715B1 (en) | cosmetic composition for skin whitening and antiwrinkle | |
KR102443871B1 (en) | Mask pack composition for Whitening and anti wrinkle containing extract pupae of male bees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20131227 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20150205 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20150822 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20150907 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20150907 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20180830 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20180830 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20210830 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20220830 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20230821 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20240813 Start annual number: 10 End annual number: 10 |